These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21431989)

  • 21. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance of previously treated tuberculosis patients with diabetes mellitus in Shandong, China.
    Song WM; Li YF; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; An QQ; Liu SQ; Yu CB; Gao L; Yu CX; Zhang M; Li HC
    Respir Med; 2020 Mar; 163():105897. PubMed ID: 32056837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
    Gegia M; Cohen T; Kalandadze I; Vashakidze L; Furin J
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):812-6. PubMed ID: 22507372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    Kunkel A; Crawford FW; Shepherd J; Cohen T
    AIDS; 2016 Nov; 30(17):2715-2723. PubMed ID: 27782966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antituberculosis drug resistance in isolates of Mycobacterium tuberculosis complex in southeast Spain.
    Montiel Quezel-Guerraz N; Sánchez-Porto A; Ortega Torres M; Pérez Santos MJ; Acosta F; Guzman A; Correa Ruiz A; Bérmudez Ruiz P
    J Glob Antimicrob Resist; 2020 Mar; 20():183-186. PubMed ID: 31421285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    Edwards BD; Edwards J; Cooper R; Kunimoto D; Somayaji R; Fisher D
    PLoS One; 2020; 15(3):e0229691. PubMed ID: 32155169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
    Melzer M; Gupta N; Petersen I; Cook S; Hall B
    Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F
    J Antimicrob Chemother; 2017 Mar; 72(3):876-881. PubMed ID: 27999054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees.
    Liu Y; Posey DL; Yang Q; Weinberg MS; Maloney SA; Lambert LA; Ortega LS; Marano N; Cetron MS; Phares CR
    Ann Am Thorac Soc; 2022 Jun; 19(6):943-951. PubMed ID: 34941475
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide survey of drug-resistant tuberculosis in the United States.
    Bloch AB; Cauthen GM; Onorato IM; Dansbury KG; Kelly GD; Driver CR; Snider DE
    JAMA; 1994 Mar; 271(9):665-71. PubMed ID: 8080502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Swe TL; Lwin T; Htwe MM; Kim KJ; Lee JS; Kim CK; Cho SN; Song SD; Chang CL
    Ann Lab Med; 2015 Sep; 35(5):494-9. PubMed ID: 26206685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis.
    Wang TY; Lin SM; Shie SS; Chou PC; Huang CD; Chung FT; Kuo CH; Chang PJ; Kuo HP
    PLoS One; 2014; 9(1):e86316. PubMed ID: 24466020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
    Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
    BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    BMC Infect Dis; 2010 Feb; 10():43. PubMed ID: 20187977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype MTBDR plus assay for molecular detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Sharma S; Madan M; Agrawal C; Asthana AK
    Indian J Pathol Microbiol; 2014; 57(3):423-6. PubMed ID: 25118735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009.
    Papaventsis D; Nikolaou S; Karabela S; Ioannidis P; Konstantinidou E; Marinou I; Sainti A; Kanavaki S
    Euro Surveill; 2010 Jul; 15(28):. PubMed ID: 20650053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.